Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
European Heart Journal Open|June 12, 2026
Asymptomatic and symptomatic cardiac toxicity associated with immune checkpoint inhibitors: insights from a Japanese registryYudai Tamura, Yuichi Tamura, Hiroshi Ohtsu, et al.
JACC. Asia|May 20, 2024
Pulmonary Hypertension With Interstitial Pneumonia: Initial Treatment Effectiveness and Severity in a Japan RegistryNobuhiro Tanabe, Hiraku Kumamaru, Yuichi Tamura, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 16, 2018
Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysisHiroki Maruyama, Kaori Miyata, Mariko Mikame, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 14, 2018
Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysisHiroki Maruyama, Kaori Miyata, Mariko Mikame, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 8, 2019
Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysisHiroki Maruyama, Kaori Miyata, Mariko Mikame, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 8, 2018
Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysisHiroki Maruyama, Kaori Miyata, Mariko Mikame, et al.
Orphanet Journal of Rare Diseases|June 13, 2019
Triglyceride deposit cardiomyovasculopathy: a rare cardiovascular disorderMing Li, Ken-Ichi Hirano, Yoshihiko Ikeda, et al.
Journal of Thrombosis and Haemostasis : JTH|June 18, 2026
Long-term real-world effectiveness and safety of edoxaban in chronic thromboembolic pulmonary hypertension: a nationwide registry studyKazuya Hosokawa, Masaki Kohei, Masayuki Hirose, et al.
European Journal of Heart Failure|July 1, 2021
Post-discharge arrhythmic risk stratification of patients with acute myocarditis and life-threatening ventricular tachyarrhythmiasPiero Gentile, Marco Merlo, Giovanni Peretto, et al.
Advances in Therapy|October 9, 2025
Immunosuppressive Therapy for Pulmonary Arterial Hypertension Associated with Connective Tissue Diseases: Insights from Japanese RegistryYudai Tamura, Yuichi Tamura, Ryo Takemura, et al.
Pageof 12